Peer-influenced content. Sources you trust. No registration required. This is HCN.
Clinical Advances in Hematology & Oncology
Uncover the potential of nivolumab and axicabtagene ciloleucel as they showcase promising results in the latest lymphoma trials, potentially reshaping the standard of care for these malignancies.
Hematology/Oncology July 25th 2023
Oncology Learning Network
The MAJIC-PV study offers new insights into the use of ruxolitinib for polycythemia vera patients intolerant to hydroxycarbamide, emphasizing its role in extending survival and improving response rates.
Hematology July 18th 2023